Shengji Yu
- Pharmaceutical Science top 5%
-
- Vascular Tumors and Angiosarcomas 5
- Cancer Cells and Metastasis 4
-
- Immunotherapy and Immune Responses 5
-
- Sarcoma Diagnosis and Treatment 15
-
- Reconstructive Surgery and Microvascular Techniques 8
- Management of metastatic bone disease 7
- Spinal Fractures and Fixation Techniques 6
-
- Spine and Intervertebral Disc Pathology 5
- Co-authors
- Xiaoyang LiJin YuanHai WangGuangjun NieYue YinHaixia MaDi YuJie Zhang
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Shengji Yu
45 papers receiving 753 citations
Peers
Comparison fields: 5 of 88
- Pharmaceutical Science 73
- Cancer Research 139
- Oncology 194
- Immunology 150
- Molecular Biology 304
Countries citing papers authored by Shengji Yu
This map shows the geographic impact of Shengji Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengji Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengji Yu more than expected).
Fields of papers citing papers by Shengji Yu
This network shows the impact of papers produced by Shengji Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengji Yu. The network helps show where Shengji Yu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengji Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 67 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 12 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 20 | |
| 10 | 2021 | 100 | |
| 11 | 2021 | 160 | |
| 12 | 2021 | 18 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 4 | |
| 16 | 2019 | 26 | |
| 17 | 2018 | 5 | |
| 18 | 2017 | 6 | |
| 19 | 2015 | 17 | |
| 20 | 2013 | 3 |
About Shengji Yu
Shengji Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 47 papers that have together received 763 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (15 papers), Reconstructive Surgery and Microvascular Techniques (8 papers), Management of metastatic bone disease (7 papers), Spinal Fractures and Fixation Techniques (6 papers), Vascular Tumors and Angiosarcomas (5 papers), Immunotherapy and Immune Responses (5 papers), Spine and Intervertebral Disc Pathology (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Pharmaceutical Science (73 citations), Cancer Research (139 citations) and Oncology (194 citations). Shengji Yu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Xiaoyang Li, Jin Yuan, Hai Wang, Guangjun Nie, Yue Yin, Haixia Ma, Di Yu, Jie Zhang, Xiaoyang Li and Libin Xu. Their work appears in journals such as Advanced Materials, Nano Letters and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.